In 2018, the group of corporate leaders banded together in support of a close friend and brain cancer survivor with a commitment to advancing pediatric brain cancer research and care.

They began the Business Executive Committee (the “BEC”) and partnered with the Preston Robert Tisch Brain Tumor Center at Duke University, one of the best pediatric and adult neuro-oncology programs in the world.

Seeing the tremendous need in helping families battling a pediatric brain tumor and supporting a robust research program, the BEC implemented the Destination Hope at Duke program.

The program covers travel and other expenses for pediatric brain tumor patients and their families in financial need, allowing swift access to groundbreaking treatments at a time when they need it most.

The Pediatric Advisory Council (the “PAC”) was launched to assist the BEC in carrying out its objective of advancing pediatric brain tumor care with a particular focus on the development and growth of research funding.

In just 7 years, the BEC has raised almost $8 million to support the development of treatments and clinical trials that traditional research funding doesn’t support. 

Without these funds, many clinical trials wouldn’t have the support to launch and many more innovations would never be discovered.